Medication Assisted Treatment (MAT) Commission

The Medication Assisted Treatment (MAT) Commission is chaired by the Commissioner of the Department of Public Health to study the impact and outcomes of Medication Assisted Treatment.

Who we serve

The Medication Assisted Treatment (MAT) Commission was established in August 2018 with Governor Baker’s signing into law of chapter 208 of the Acts of 2018. The commission is charged with: create aggregate demographic and geographic profiles of individuals who use medication-assisted treatment; examine the availability of and barriers to accessing medication-assisted treatment, including federal, state and local laws and regulations; determining the current utilization of, and projected need for, medication-assisted treatment in inpatient and outpatient settings, including, but not limited to, inpatient and residential substance use treatment facilities, inpatient psychiatric settings, pharmacy settings, mobile settings and primary care settings; identify ways to expand access to medication-assisted treatment in both inpatient and outpatient settings; identify ways to encourage practitioners to seek waivers to administer buprenorphine to treat patients with opioid use disorder; study the availability of and concurrent use of behavioral health therapy for individuals receiving medication-assisted treatment; and other related matters.

Upcoming Events from Medication Assisted Treatment (MAT) Commission

No upcoming events scheduled
Feedback